Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP163779.RAbyUlKAc87zdhKEBVPzTANpt88_T4aEC8fHhnq5UKuMc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP163779.RAbyUlKAc87zdhKEBVPzTANpt88_T4aEC8fHhnq5UKuMc130_assertion type Assertion NP163779.RAbyUlKAc87zdhKEBVPzTANpt88_T4aEC8fHhnq5UKuMc130_head.
- NP163779.RAbyUlKAc87zdhKEBVPzTANpt88_T4aEC8fHhnq5UKuMc130_assertion description "[Expression of dominant-negative PPARgamma reverses transcriptional activation of 15-lipoxygenase-2 promoter by enhancing it 202-fold in normal prostate epithelial cells or suppressing it in prostate carcinoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP163779.RAbyUlKAc87zdhKEBVPzTANpt88_T4aEC8fHhnq5UKuMc130_provenance.
- NP163779.RAbyUlKAc87zdhKEBVPzTANpt88_T4aEC8fHhnq5UKuMc130_assertion evidence source_evidence_literature NP163779.RAbyUlKAc87zdhKEBVPzTANpt88_T4aEC8fHhnq5UKuMc130_provenance.
- NP163779.RAbyUlKAc87zdhKEBVPzTANpt88_T4aEC8fHhnq5UKuMc130_assertion SIO_000772 16682954 NP163779.RAbyUlKAc87zdhKEBVPzTANpt88_T4aEC8fHhnq5UKuMc130_provenance.
- NP163779.RAbyUlKAc87zdhKEBVPzTANpt88_T4aEC8fHhnq5UKuMc130_assertion wasDerivedFrom lhgdn-20090331 NP163779.RAbyUlKAc87zdhKEBVPzTANpt88_T4aEC8fHhnq5UKuMc130_provenance.
- NP163779.RAbyUlKAc87zdhKEBVPzTANpt88_T4aEC8fHhnq5UKuMc130_assertion wasGeneratedBy ECO_0000203 NP163779.RAbyUlKAc87zdhKEBVPzTANpt88_T4aEC8fHhnq5UKuMc130_provenance.